SB
WST icon

Suntrust Banks’s West Pharmaceutical WST Stock Holding History

Suntrust Banks’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5.37M Sell
37,882
-4,234
-10% -$583K 0.03% 338
2019
Q2 		$5.27M Buy
42,116
+448
+1% +$52.9K 0.03% 341
2019
Q1 		$4.59M Buy
41,668
+143
+0.3% +$14.9K 0.02% 351
2018
Q4 		$4.07M Buy
41,525
+1,741
+4% +$189K 0.02% 353
2018
Q3 		$4.91M Buy
39,784
+348
+0.9% +$39K 0.03% 327
2018
Q2 		$3.92M Buy
39,436
+247
+0.6% +$22.7K 0.02% 373
2018
Q1 		$3.46M Buy
39,189
+2,521
+7% +$236K 0.02% 383
2017
Q4 		$3.62M Buy
36,668
+585
+2% +$57.4K 0.02% 338
2017
Q3 		$3.47M Buy
36,083
+25,412
+238% +$2.3M 0.02% 369
2017
Q2 		$1.01M Buy
10,671
+336
+3% +$30.9K 0.01% 656
2017
Q1 		$843K Buy
10,335
+639
+7% +$53.4K 0.01% 690
2016
Q4 		$821K Buy
9,696
+547
+6% +$43K ﹤0.01% 834
2016
Q3 		$679K Buy
9,149
+166
+2% +$13.2K ﹤0.01% 858
2016
Q2 		$680K Buy
8,983
+808
+10% +$58.8K ﹤0.01% 838
2016
Q1 		$565K Sell
8,175
-637
-7% -$38.3K ﹤0.01% 892
2015
Q4 		$529K Sell
8,812
-694
-7% -$41.8K ﹤0.01% 920
2015
Q3 		$513K Sell
9,506
-223
-2% -$13K ﹤0.01% 868
2015
Q2 		$564K Buy
9,729
+204
+2% +$11.4K ﹤0.01% 815
2015
Q1 		$572K Buy
9,525
+395
+4% +$21.1K ﹤0.01% 789
2014
Q4 		$485K Buy
9,130
+727
+9% +$36.4K ﹤0.01% 820
2014
Q3 		$375K Buy
+8,403
New +$357K ﹤0.01% 1073
2014
Q2 		– Sell
-7,279
Closed -$318K – 1708
2014
Q1 		$318K Sell
7,279
-587
-7% -$27.6K ﹤0.01% 1543
2013
Q4 		$383K Sell
7,866
-356
-4% -$16.7K ﹤0.01% 1391
2013
Q3 		$336K Buy
8,222
+46
+0.6% +$1.75K ﹤0.01% 1427
2013
Q2 		$286K Buy
+8,176
New +$269K ﹤0.01% 1438

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Suntrust Banks's WST Position: Q3 2019 in Review

Suntrust Banks reduced its West Pharmaceutical (WST) stake by 10% in Q3 2019, selling an estimated $583K and leaving 37,882 shares worth $5.37M. The position accounts for 0.03% of the portfolio, ranked #338.

Suntrust Banks first reported a position in WST in Q2 2013 and has held it in 25 quarters since. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

  • Suntrust Banks held 37,882 shares of West Pharmaceutical worth $5.37M as of Q3 2019.
  • Suntrust Banks sold 4,234 West Pharmaceutical shares in Q3 2019, an estimated $583K.
  • West Pharmaceutical made up 0.03% of Suntrust Banks's portfolio in Q3 2019, its #338 holding.
  • Suntrust Banks first reported a position in West Pharmaceutical in Q2 2013 and has held it in 25 quarters since.
  • 406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.